Eletriptan - NDSRI's
References
FAQ's
References
- Macor, John Eugene; Wythes, Martin James, Indole Derivatives, Pfizer Inc., United States, EP592438B1, August 27, 1997
- Singh, Pradeep Kumar; Dinda, Subas Chandra, Development and validation of a stability indicating RP-HPLC method for determination of Eletriptan in Eletriptan Hydrobromide orally disintegrating tablets, International Research Journal of Pharmacy, Volume: 4, Issue: 6, Pages: 179-182, 2013
Frequently Asked Questions
What is the synthetic process of Eletriptan?
The synthesis of Eletriptan involves several chemical reactions and purification steps to obtain the desired drug molecule. It is vital to optimize the synthetic process to minimize impurity formation.
How is the quality of Eletriptan ensured?
The quality of Eletriptan is ensured through rigorous quality control measures, including the analysis and control of impurities. Regulatory guidelines define acceptable limits for impurities for manufacturers to adhere to these standards.
What solvent helps analyze Eletriptan impurities?
Methanol or Acetonitrile are the solvents used for analyzing many impurities in Eletriptan.
How should Eletriptan impurities be stored in terms of temperature?
Eletriptan impurities are stored at a controlled room temperature of 2-8 °C or according to the Certificate of Analysis (CoA) specifications.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.